Header cover image

Egyptian (CASE/EGX) Pharma Industry Analysis

UpdatedApr 17, 2025
DataAggregated Company Financials
Companies11
  • 7D2.6%
  • 3M16.8%
  • 1Y21.7%
  • YTD17.7%

The Pharma industry is up 1.8% in the last week, with Kahira Pharmaceuticals & Chemical Industries up 15%. In the last 12 months, the industry was up 23%. As for the next few years, earnings are expected to grow by 23% per annum.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 17 Apr 2025ج.م28.4bج.م26.2bج.م2.8b7.6x10.1x1.1x
Sat, 15 Mar 2025ج.م28.7bج.م26.2bج.م2.8b7.3x10.1x1.1x
Mon, 10 Feb 2025ج.م24.8bج.م23.8bج.م2.4b9.2x10.4x1x
Wed, 08 Jan 2025ج.م23.6bج.م23.7bج.م2.4b8.7x9.9x1x
Fri, 06 Dec 2024ج.م23.9bج.م23.7bج.م2.4b7x10.1x1x
Sun, 03 Nov 2024ج.م24.1bج.م22.0bج.م2.2b6.8x11.2x1.1x
Tue, 01 Oct 2024ج.م22.5bج.م22.1bج.م2.1b6.7x10.5x1x
Thu, 29 Aug 2024ج.م19.2bج.م22.1bج.م2.4b5.6x7.9x0.9x
Sat, 27 Jul 2024ج.م18.9bج.م21.3bج.م2.5b5x7.7x0.9x
Mon, 24 Jun 2024ج.م18.2bج.م20.8bج.م2.3b7x8x0.9x
Wed, 22 May 2024ج.م18.5bج.م20.1bج.م1.8b7.8x10.2x0.9x
Fri, 19 Apr 2024ج.م21.0bج.م19.3bج.م1.8b8.4x11.9x1.1x
Sun, 17 Mar 2024ج.م22.8bج.م19.2bج.م2.3b8.8x9.9x1.2x
Tue, 13 Feb 2024ج.م21.2bج.م18.5bج.م2.4b9.8x8.9x1.1x
Thu, 11 Jan 2024ج.م18.8bج.م16.0bج.م2.2b7.1x8.6x1.2x
Sat, 09 Dec 2023ج.م19.4bج.م16.5bج.م2.2b9.1x9x1.2x
Mon, 06 Nov 2023ج.م15.3bج.م15.4bج.م1.9b6.5x7.9x1x
Wed, 04 Oct 2023ج.م13.8bج.م15.3bج.م1.9b5.5x7.2x0.9x
Fri, 01 Sep 2023ج.م13.9bج.م15.9bج.م2.0b7.2x6.8x0.9x
Sun, 30 Jul 2023ج.م13.4bج.م15.6bج.م2.1b6.9x6.4x0.9x
Tue, 27 Jun 2023ج.م13.9bج.م16.2bج.م2.2b5.4x6.3x0.9x
Thu, 25 May 2023ج.م13.7bج.م16.2bج.م2.4b4.5x5.7x0.8x
Sat, 22 Apr 2023ج.م14.5bج.م16.2bج.م2.4b5.2x6x0.9x
Mon, 20 Mar 2023ج.م13.5bج.م15.7bج.م2.3b5.3x5.9x0.9x
Wed, 15 Feb 2023ج.م15.0bج.م15.6bج.م2.3b5.3x6.6x1x
Fri, 13 Jan 2023ج.م15.0bج.م15.6bج.م2.3b5.4x6.6x1x
Sun, 11 Dec 2022ج.م15.1bج.م15.6bج.م2.3b4.9x6.6x1x
Tue, 08 Nov 2022ج.م13.0bج.م15.1bج.م2.2b5.1x6x0.9x
Thu, 06 Oct 2022ج.م12.6bج.م15.1bج.م2.2b4.7x5.8x0.8x
Sat, 03 Sep 2022ج.م13.0bج.م14.3bج.م2.0b6.1x6.4x0.9x
Mon, 01 Aug 2022ج.م12.4bج.م14.1bج.م1.9b5.8x6.4x0.9x
Wed, 29 Jun 2022ج.م11.9bج.م14.1bج.م1.9b5.7x6.2x0.8x
Fri, 27 May 2022ج.م11.8bج.م11.9bج.م1.7b5.6x7.1x1x
Sun, 24 Apr 2022ج.م12.3bج.م11.9bج.م1.7b5.7x7.4x1x
Price to Earnings Ratio

7.4x


Total Market Cap: ج.م12.3bTotal Earnings: ج.م1.7bTotal Revenue: ج.م11.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Egyptian Pharma Industry Price to Earnings3Y Average 7.9x202320242025
Current Industry PE
  • Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 10.1x which is higher than its 3-year average PE of 7.9x.
  • The 3-year average PS ratio of 0.97x is lower than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 19% per year over the last three years.
  • Revenues for these companies have grown 30% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Egyptian Healthcare industry?

EG Market2.63%
Healthcare3.60%
Pharma2.58%
Pharma2.58%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CPCI Kahira Pharmaceuticals & Chemical Industriesج.م166.1621.4%
+ج.م438.2m
136.6%PE6.7x
BIOC GlaxoSmithKlineEج.م37.955.0%
+ج.م149.5m
11.6%PE18.2x
PHAR Egyptian International Pharmaceutical Industriesج.م50.701.4%
+ج.م104.1m
8.4%PE6.9x
MIPH MINAPHARM Pharmaceuticalsج.م180.374.0%
+ج.م77.1m
-20.0%PS0.5x
MPCI Memphis Pharmaceuticals & Chemical Industriesج.م74.243.2%
+ج.م52.8m
-22.7%PE4.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

RMDA

ج.م4.32

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E

7D

-0.5%

1Y

65.5%

PHAR

ج.م50.70

Egyptian International Pharmaceutical Industries

7D

1.4%

1Y

8.4%

BIOC

ج.م37.95

GlaxoSmithKlineE

7D

5.0%

1Y

11.6%

CPCI

ج.م166.16

Kahira Pharmaceuticals & Chemical Industries

7D

21.4%

1Y

136.6%

ADCI

ج.م156.60

Arab Drug

7D

-1.2%

1Y

67.2%

MIPH

ج.م180.37

MINAPHARM Pharmaceuticals

7D

4.0%

1Y

-20.0%